CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) shares in Millions, $ in Millions | Total | Common Stock | Treasury Shares | Paid-In Capital | Accumulated Other Comprehensive Income | Retained Earnings |
Beginning balance (in shares) at Dec. 31, 2021 | | 893 | | | | |
Beginning balance (in shares) at Dec. 31, 2021 | | | 79 | | | |
Balance at beginning of period at Dec. 31, 2021 | $ 11,738 | $ 89 | $ (1,826) | $ 10,911 | $ 1 | $ 2,563 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 608 | | | | | 608 |
Exercise of stock options | 6 | | | 6 | | |
Stock amortization and vesting | 10 | | | 10 | | |
Common stock repurchases (in shares) | | | 8 | | | |
Common stock repurchases | (192) | | $ (192) | | | |
Common stock cash dividends | (455) | | | | | (455) |
Preferred stock cash dividends | (1) | | | | | (1) |
Other comprehensive (loss) income | 4 | | | | 4 | |
Ending balance (in shares) at Mar. 31, 2022 | | 893 | | | | |
Ending balance (in shares) at Mar. 31, 2022 | | | 87 | | | |
Balance at end of period at Mar. 31, 2022 | 11,718 | $ 89 | $ (2,018) | 10,927 | 5 | 2,715 |
Beginning balance (in shares) at Dec. 31, 2021 | | 893 | | | | |
Beginning balance (in shares) at Dec. 31, 2021 | | | 79 | | | |
Balance at beginning of period at Dec. 31, 2021 | 11,738 | $ 89 | $ (1,826) | 10,911 | 1 | 2,563 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | $ 3,033 | | | | | |
Common stock repurchases (in shares) | (28) | | | | | |
Common stock repurchases | $ (740) | | | | | |
Ending balance (in shares) at Sep. 30, 2022 | | 895 | | | | |
Ending balance (in shares) at Sep. 30, 2022 | | | 107 | | | |
Balance at end of period at Sep. 30, 2022 | 12,659 | $ 90 | $ (2,566) | 10,992 | 6 | 4,137 |
Beginning balance (in shares) at Mar. 31, 2022 | | 893 | | | | |
Beginning balance (in shares) at Mar. 31, 2022 | | | 87 | | | |
Balance at beginning of period at Mar. 31, 2022 | 11,718 | $ 89 | $ (2,018) | 10,927 | 5 | 2,715 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 1,229 | | | | | 1,229 |
Exercise of stock options | 3 | | | 3 | | |
Stock amortization and vesting | 18 | | | 18 | | |
Conversion of Cimarex redeemable preferred stock (in shares) | | 1 | | | | |
Conversion of Cimarex redeemable preferred stock | 28 | | | 28 | | |
Common stock repurchases (in shares) | | | 12 | | | |
Common stock repurchases | (321) | | $ (321) | | | |
Common stock cash dividends | (484) | | | | | (484) |
Ending balance (in shares) at Jun. 30, 2022 | | 894 | | | | |
Ending balance (in shares) at Jun. 30, 2022 | | | 99 | | | |
Balance at end of period at Jun. 30, 2022 | 12,191 | $ 89 | $ (2,339) | 10,976 | 5 | 3,460 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 1,196 | | | | | 1,196 |
Exercise of stock options | 2 | | | 2 | | |
Stock amortization and vesting (in shares) | | 1 | | | | |
Stock amortization and vesting | 15 | $ 1 | | 14 | | |
Common stock repurchases (in shares) | | | 8 | | | |
Common stock repurchases | (227) | | $ (227) | | | |
Common stock cash dividends | (519) | | | | | (519) |
Other comprehensive (loss) income | 1 | | | | 1 | |
Ending balance (in shares) at Sep. 30, 2022 | | 895 | | | | |
Ending balance (in shares) at Sep. 30, 2022 | | | 107 | | | |
Balance at end of period at Sep. 30, 2022 | 12,659 | $ 90 | $ (2,566) | 10,992 | 6 | 4,137 |
Beginning balance (in shares) at Dec. 31, 2022 | | 768 | | | | |
Beginning balance (in shares) at Dec. 31, 2022 | | | 0 | | | |
Balance at beginning of period at Dec. 31, 2022 | 12,659 | $ 77 | $ 0 | 7,933 | 13 | 4,636 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 677 | | | | | 677 |
Stock amortization and vesting | 13 | | | 13 | | |
Conversion of Cimarex redeemable preferred stock | 3 | | | 3 | | |
Common stock repurchases (in shares) | | | 11 | | | |
Common stock repurchases | (271) | | $ (271) | | | |
Common stock retirements (in shares) | | (11) | (11) | | | |
Common stock retirements | 0 | $ (1) | $ 271 | (270) | | |
Common stock cash dividends | (438) | | | | | (438) |
Ending balance (in shares) at Mar. 31, 2023 | | 757 | | | | |
Ending balance (in shares) at Mar. 31, 2023 | | | 0 | | | |
Balance at end of period at Mar. 31, 2023 | 12,643 | $ 76 | $ 0 | 7,679 | 13 | 4,875 |
Beginning balance (in shares) at Dec. 31, 2022 | | 768 | | | | |
Beginning balance (in shares) at Dec. 31, 2022 | | | 0 | | | |
Balance at beginning of period at Dec. 31, 2022 | 12,659 | $ 77 | $ 0 | 7,933 | 13 | 4,636 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 1,209 | | | | | |
Ending balance (in shares) at Sep. 30, 2023 | | 753 | | | | |
Ending balance (in shares) at Sep. 30, 2023 | | | 0 | | | |
Balance at end of period at Sep. 30, 2023 | 12,789 | $ 75 | $ 0 | 7,601 | 12 | 5,101 |
Beginning balance (in shares) at Mar. 31, 2023 | | 757 | | | | |
Beginning balance (in shares) at Mar. 31, 2023 | | | 0 | | | |
Balance at beginning of period at Mar. 31, 2023 | 12,643 | $ 76 | $ 0 | 7,679 | 13 | 4,875 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 209 | | | | | 209 |
Stock amortization and vesting | 17 | | | 17 | | |
Common stock repurchases (in shares) | | | 2 | | | |
Common stock repurchases | (57) | | $ (57) | | | |
Common stock retirements (in shares) | | (2) | (2) | | | |
Common stock retirements | 0 | | $ 57 | (57) | | |
Common stock cash dividends | (153) | | | | | (153) |
Ending balance (in shares) at Jun. 30, 2023 | | 755 | | | | |
Ending balance (in shares) at Jun. 30, 2023 | | | 0 | | | |
Balance at end of period at Jun. 30, 2023 | 12,659 | $ 76 | $ 0 | 7,639 | 13 | 4,931 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 323 | | | | | 323 |
Stock amortization and vesting | 21 | | | 21 | | |
Common stock repurchases (in shares) | | | 2 | | | |
Common stock repurchases | (60) | | $ (60) | | | |
Common stock retirements (in shares) | | (2) | (2) | | | |
Common stock retirements | 0 | $ (1) | $ 60 | (59) | | |
Common stock cash dividends | (153) | | | | | (153) |
Other comprehensive (loss) income | (1) | | | | (1) | |
Ending balance (in shares) at Sep. 30, 2023 | | 753 | | | | |
Ending balance (in shares) at Sep. 30, 2023 | | | 0 | | | |
Balance at end of period at Sep. 30, 2023 | $ 12,789 | $ 75 | $ 0 | $ 7,601 | $ 12 | $ 5,101 |